Allogeneic Wharton Jelly Mesenchymal Cells (WJMSC)

Wharton jelly mesenchymal stromal cells · University of Jordan

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Allogeneic Wharton Jelly Mesenchymal Cells (WJMSC), covering 2025-01-24 to 2025-01-24. Get the full timeline:

Most recent: Clinical Trial Update: Allogeneic Wharton Jelly Mesenchymal Stromal Cell (WJMSC) for Treatment of Autism [Phase 1]

See pricing